Original Research
Published on 12 Sep 2025
Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes
in Clinical Diabetes
Frontiers in Endocrinology
doi 10.3389/fendo.2025.1670266
- 2,535 views
- 1 citation

